WallStreetZenWallStreetZen

NASDAQ: WORX
Scworx Corp Stock

$2.35+0.03 (+1.29%)
Updated Apr 18, 2024
WORX Price
$2.35
Fair Value Price
N/A
Market Cap
$2.85M
52 Week Low
$1.14
52 Week High
$14.40
P/E
-2.94x
P/B
0.46x
P/S
12.96x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.92M
Earnings
-$1.67M
Gross Margin
34.2%
Operating Margin
-42.43%
Profit Margin
-42.6%
Debt to Equity
0.43
Operating Cash Flow
-$814k
Beta
0.27
Next Earnings
May 15, 2024
Ex-Dividend
N/A
Next Dividend
N/A

WORX Overview

SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. It also offers virtualized item master file repair, expansion and automation; EMR management; CDM management; contract management; request for proposal automation; rebate management; integration of acquired management; big data analytics modeling; data integration and warehousing; and ScanWorx. In addition, the company operates an online event ticketing platform focused on serving regional mixed martial arts. In addition, it offers CageTix, a ticketing platform for mixed martial arts industry. Further, the company focuses on selling personal protective equipment and COVID-19 rapid test kits. It sells its solutions and services to hospitals and health systems through its direct sales force, and distribution and reseller partnerships. SCWorx Corp. is based in New York, New York.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how WORX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

WORX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
WORX is good value based on its book value relative to its share price (0.46x), compared to the US Health Information Services industry average (3.36x)
P/B vs Industry Valuation
WORX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more WORX due diligence checks available for Premium users.

Be the first to know about important WORX news, forecast changes, insider trades & much more!

WORX News

Valuation

WORX fair value

Fair Value of WORX stock based on Discounted Cash Flow (DCF)
Price
$2.35
Fair Value
$1.74
Overvalued by
35.24%
WORX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

WORX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.94x
Industry
74.25x
Market
41.33x

WORX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.46x
Industry
3.36x
WORX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

WORX's financial health

Profit margin

Revenue
$906.1k
Net Income
-$858.3k
Profit Margin
-94.7%
WORX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
WORX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$8.8M
Liabilities
$2.7M
Debt to equity
0.43
WORX's short-term liabilities ($2.56M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
WORX's short-term assets ($450.15k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
WORX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
WORX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$372.8k
Investing
$0.0
Financing
$312.2k
WORX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

WORX vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
WORX$2.85M+1.29%-2.94x0.46x
FOXO$2.48M+2.21%-0.02x-0.22x
ACON$2.12M0.00%-0.03x-2.92x
ZCMD$3.77M+5.84%-0.49x0.16x
HCTI$6.48M+5.61%-0.48x12.05x

Scworx Stock FAQ

What is Scworx's quote symbol?

(NASDAQ: WORX) Scworx trades on the NASDAQ under the ticker symbol WORX. Scworx stock quotes can also be displayed as NASDAQ: WORX.

If you're new to stock investing, here's how to buy Scworx stock.

What is the 52 week high and low for Scworx (NASDAQ: WORX)?

(NASDAQ: WORX) Scworx's 52-week high was $14.40, and its 52-week low was $1.14. It is currently -83.68% from its 52-week high and 106.14% from its 52-week low.

How much is Scworx stock worth today?

(NASDAQ: WORX) Scworx currently has 1,211,035 outstanding shares. With Scworx stock trading at $2.35 per share, the total value of Scworx stock (market capitalization) is $2.85M.

Scworx stock was originally listed at a price of $1,194.15 in Oct 6, 2016. If you had invested in Scworx stock at $1,194.15, your return over the last 7 years would have been -99.8%, for an annualized return of -58.94% (not including any dividends or dividend reinvestments).

How much is Scworx's stock price per share?

(NASDAQ: WORX) Scworx stock price per share is $2.35 today (as of Apr 18, 2024).

What is Scworx's Market Cap?

(NASDAQ: WORX) Scworx's market cap is $2.85M, as of Apr 19, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Scworx's market cap is calculated by multiplying WORX's current stock price of $2.35 by WORX's total outstanding shares of 1,211,035.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.